Genomics PLC solves the data challenge of genomics for pharmaceutical providers and governments, driving transformation in the healthcare landscape.
Genomics develop and apply sophisticated analyses of its world-leading database of integrated genomic and phenotypic datasets, to uncover the relationships between genetic variation and human disease. Working with healthcare providers, the Company is able to de-risk the drug development process by identifying which drugs are most likely to succeed in clinical trial – a game changer for pharmaceuticals and biotechnology.
Genomics was founded by the world’s number one genetics research team, from the Wellcome Trust Centre for Human Genetics at Oxford University. Tanarra invested in Genomics in November 2014.